The role of intravenous Lidocain as sedative and analgesic for the reduction of anterior shoulder dislocation in refereed to Emergency ward of hospital

Not Applicable

• Conditions: S43.01; anterior shoulder dislocation.; Anterior subluxation and dislocation of humerus

• Registration Number: IRCT2016101730353N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All patients with anterior shoulder dislocation
Exclusion criteria: All patients with loss of consciousness; the patient who has shoulder fracture(except hill-sachs lesion); past medical history of shoulder surgery or shoulder fracture; past medical history of epilepsy; cardiac disease or dysrhythmia drug history of using digoxin; all patient with allergy to lidocain midazolam or fentanyl

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of pain. Timepoint: before sedation and after full conciousnes. Method of measurement: according to VAS (Visual Analog Scale).

Secondary Outcome Measures

Name	Time	Method
Drug`s side effects: apnea, oxigen saturation decrease less than 90 percent, dysrhytmia, other. Timepoint: after full consciousness. Method of measurement: questionair.